<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38455946</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2674-1199</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in epidemiology</Title><ISOAbbreviation>Front Epidemiol</ISOAbbreviation></Journal><ArticleTitle>The prolonged impact of COVID-19 on symptoms, health-related quality of life, fatigue and mental well-being: a cross-sectional study.</ArticleTitle><Pagination><StartPage>1144707</StartPage><MedlinePgn>1144707</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1144707</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fepid.2023.1144707</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">A subset of patients experience persisting symptoms after an acute COVID-19 infection, referred to as "post COVID-19 condition". This cross-sectional study aimed to compare symptoms, health-related quality of life (HRQoL), fatigue, mental well-being, and determinants of diminished HRQoL, between patients with post COVID-19 condition categorized by time since acute infection.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We performed an online survey and analyzed responses of 10,194 adult respondents with a confirmed or suspected COVID-19 infection, who experienced persisting symptoms &#x2265;3 months after the initial infection. The most debilitating symptoms and health outcomes were studied separately for respondents 3-6, 7-9, 10-12, 13-18, 19-24, and &gt;24 months after acute infection.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">At each time period, fatigue, sensory-processing problems, and concentration problems were the most debilitating symptoms reported by respondents, although the proportion of respondents who reported these symptoms differed significantly between time periods. Respondents 3-6 months post-acute infection had the lowest HRQoL (median EQ-5D utility score: 0.59), the highest fatigue level (median score: 110.0) and the highest proportion with a likely depressive disorder (32.4%), whereas respondents 13-18 months post-infection had the highest HRQoL (0.65), the lowest fatigue level (106.0), and the second lowest proportion with a likely depressive disorder (25.0%) (<i>p</i>&#x2009;=&#x2009;0.000-0.007). Compared to those 13-18 and 19-24 months post-infection, respondents &gt;24 months post-infection had a slightly lower HRQoL (0.60), lower fatigue level (108.0), and lower proportion with a likely depressive disorder (29.2%), although only the differences in HRQoL were statistically significant (<i>p</i>&#x2009;=&#x2009;0.001-0.010). Younger age, female gender, lower level of education, not having paid work before COVID-19, comorbidity, and not being vaccinated, seemed to be associated with lower HRQoL.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Regardless of time since infection, respondents considered fatigue, sensory processing problems and concentration problems the most debilitating symptoms. They experienced a low HRQoL and severe fatigue, even more than two years after acute COVID-19 infection. Respondents 3-6&#x2005;months post-infection had the worst health outcomes, whereas respondents 13-18&#x2005;months post-infection had the best outcomes, indicating that, at least for a subgroup of patients, health status may improve over time.</AbstractText><CopyrightInformation>&#xa9; 2023 Brus, Spronk, Haagsma, de Groot, Tieleman, Biere-Rafi and Polinder.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brus</LastName><ForeName>Iris M</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Department of Public Health, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spronk</LastName><ForeName>Inge</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Public Health, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haagsma</LastName><ForeName>Juanita A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Public Health, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Groot</LastName><ForeName>Annemieke</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>C-support, 's Hertogenbosch, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tieleman</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>C-support, 's Hertogenbosch, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biere-Rafi</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>C-support, 's Hertogenbosch, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polinder</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Public Health, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Epidemiol</MedlineTA><NlmUniqueID>9918419158106676</NlmUniqueID><ISSNLinking>2674-1199</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">health-related quality of life (HRQL)</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">mental well-being</Keyword><Keyword MajorTopicYN="N">post COVID-19 condition</Keyword><Keyword MajorTopicYN="N">symptoms</Keyword></KeywordList><CoiStatement>Authors AG, PT and SB were employed by the organization C-support. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>8</Day><Hour>4</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38455946</ArticleId><ArticleId IdType="pmc">PMC10911032</ArticleId><ArticleId IdType="doi">10.3389/fepid.2023.1144707</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. WHO Coronavirus (COVID-19) Dashboard (2022). Available at:
https://covid19.who.int/
(Accessed December 14, 2022).</Citation></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, on behalf of the WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a delphi consensus. Lancet Infect Dis. (2022) 22(4):e102&#x2013;7. 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long CC, Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. (2022) 328(16):1604&#x2013;15. 10.1001/jama.2022.18931</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, Lifelines Corona Research I. Persistence of somatic symptoms after COVID-19 in The Netherlands: an observational cohort study. Lancet. (2022) 400(10350):452&#x2013;61. 10.1016/S0140-6736(22)01214-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips S, Williams MA. Confronting our next national health disaster&#x2014;long-haul COVID. N Engl J Med. (2021) 385(7):577&#x2013;9. 10.1056/NEJMp2109285</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2109285</ArticleId><ArticleId IdType="pubmed">34192429</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). (2021) 53(10):737&#x2013;54. 10.1080/23744235.2021.1924397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long COVID-mechanisms, risk factors, and management. Br Med J. (2021) 374:n1648. 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. (2021) 4(5):e2111417. 10.1001/jamanetworkopen.2021.11417</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, Florencio LL, Cuadrado ML, Plaza-Manzano G, et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur J Intern Med. (2021) 92:55&#x2013;70. 10.1016/j.ejim.2021.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Zheng B, Daines L, Sheikh A. Long-Term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. (2022) 11(2):269. 10.3390/pathogens11020269</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Rodr&#xed;guez-Jim&#xe9;nez J, Cancela-Cilleruelo I, Guerrero-Peral A, Mart&#xed;n-Guerrero JD, Garc&#xed;a-Azor&#xed;n D, et al. Post-COVID-19 symptoms 2 years after SARS-CoV-2 infection among hospitalized vs nonhospitalized patients. JAMA Netw Open. (2022) 5(11):e2242106. 10.1001/jamanetworkopen.2022.42106</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.42106</ArticleId><ArticleId IdType="pmc">PMC9667330</ArticleId><ArticleId IdType="pubmed">36378309</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month Neurological and psychiatric outcomes in 236&#x2009;379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. (2021) 8(5):416&#x2013;27. 10.1016/S2215-0366(21)00084-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P, Patel K, Pinto C, Jaiswal R, Tirupathi R, Pillai S, et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-analysis. J Med Virol. (2022) 94(1):253&#x2013;62. 10.1002/jmv.27309</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. (2021) 38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Nicholson TR, Needham DM, Seylanova N, Parr C, Chen J, et al. Studying the post-COVID-19 condition: research challenges, strategies, and importance of core outcome set development. BMC Med. (2022) 20(1):50. 10.1186/s12916-021-02222-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02222-y</ArticleId><ArticleId IdType="pmc">PMC8813480</ArticleId><ArticleId IdType="pubmed">35114994</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi MS, Omrani OA, Fawzy NA, Shaar BA, Almamlouk R, Riaz M, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. (2022) 28(5):657&#x2013;66. 10.1016/j.cmi.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet T. Understanding long COVID: a modern medical challenge. Lancet. (2021) 398(10302):725. 10.1016/S0140-6736(21)01900-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01900-0</ArticleId><ArticleId IdType="pmc">PMC8389978</ArticleId><ArticleId IdType="pubmed">34454656</ArticleId></ArticleIdList></Reference><Reference><Citation>Statistics Netherlands (CBS). Opleidingsniveau. Available at:
https://www.cbs.nl/nl-nl/nieuws/2019/33/verschil-levensverwachting-hoog-en-laagopgeleid-groeit/opleidingsniveau
(Accessed December 14, 2022).</Citation></Reference><Reference><Citation>WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. (2000) 894(i&#x2013;xii):1&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">11234459</ArticleId></ArticleIdList></Reference><Reference><Citation>Statistics Netherlands (CBS). CBS: Permanent onderzoek leefsituatie. Voorburg/Heerlen: Statistics Netherlands (CBS) (2003).</Citation></Reference><Reference><Citation>Tong A, Baumgart A, Evangelidis N, Viecelli AK, Carter SA, Azevedo LC, et al. Core outcome measures for trials in people with coronavirus disease 2019: respiratory failure, multiorgan failure, shortness of breath, and recovery. Crit Care Med. (2021) 49(3):503&#x2013;16. 10.1097/CCM.0000000000004817</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004817</ArticleId><ArticleId IdType="pmc">PMC7892260</ArticleId><ArticleId IdType="pubmed">33400475</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Nicholson T, Akrami A, Apfelbacher C, Chen J, De Groote W, et al. A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international delphi consensus study. Lancet Respir Med. (2022) 10(7):715&#x2013;24. 10.1016/S2213-2600(22)00169-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00169-2</ArticleId><ArticleId IdType="pmc">PMC9197249</ArticleId><ArticleId IdType="pubmed">35714658</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5l). Qual Life Res. (2011) 20(10):1727&#x2013;36. 10.1007/s11136-011-9903-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-011-9903-x</ArticleId><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Versteegh MM, Vermeuelen KM, Evers SMAA, de Wit GA, Prenger R, Stolk EA. Dutch Tariff for the five-level version of EQ-5D. Value Health. (2016) 19(4):343&#x2013;52. 10.1016/j.jval.2016.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2016.01.003</ArticleId><ArticleId IdType="pubmed">27325326</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercoulen J, Alberts M, Bleijenberg G. De checklist individuele spankracht (CIS). Gedragstherapie. (1999) 32(131):6.</Citation></Reference><Reference><Citation>Worm-Smeitink M, Gielissen M, Bloot L, van Laarhoven HWM, van Engelen BGM, van Riel P, et al. The assessment of fatigue: psychometric qualities and norms for the checklist individual strength. J Psychosom Res. (2017) 98:40&#x2013;6. 10.1016/j.jpsychores.2017.05.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2017.05.007</ArticleId><ArticleId IdType="pubmed">28554371</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. Myalgic encephalomyelitis: international consensus criteria. J Intern Med. (2011) 270(4):327&#x2013;38. 10.1111/j.1365-2796.2011.02428.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Plummer F, Manea L, Trepel D, McMillan D. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. Gen Hosp Psychiatry. (2016) 39:24&#x2013;31. 10.1016/j.genhosppsych.2015.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2015.11.005</ArticleId><ArticleId IdType="pubmed">26719105</ArticleId></ArticleIdList></Reference><Reference><Citation>Levis B, Sun Y, He C, Wu Y, Krishnan A, Bhandari PM, et al. Accuracy of the PHQ-2 alone and in combination with the PHQ-9 for screening to detect Major depression: systematic review and meta-analysis. JAMA. (2020) 323(22):2290&#x2013;300. 10.1001/jama.2020.6504</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6504</ArticleId><ArticleId IdType="pmc">PMC7284301</ArticleId><ArticleId IdType="pubmed">32515813</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T, Yan MZ, Li X, Lau EHY. Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysis. Infection. (2022) 50(5):1067&#x2013;109. 10.1007/s15010-022-01862-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01862-3</ArticleId><ArticleId IdType="pmc">PMC9244338</ArticleId><ArticleId IdType="pubmed">35750943</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran VT, Porcher R, Pane I, Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat Commun. (2022) 13(1):1812. 10.1038/s41467-022-29513-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatcheva KP, Lee M, McCormick JB, Rahbar MH. Multicollinearity in regression analyses conducted in epidemiologic studies. Epidemiology (Sunnyvale). (2016) 6(2):227. 10.4172/2161-1165.1000227</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2161-1165.1000227</ArticleId><ArticleId IdType="pmc">PMC4888898</ArticleId><ArticleId IdType="pubmed">27274911</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter RS, Nieters A, Kr&#xe4;usslich HG, Brockmann SO, G&#xf6;pel S, Kindle G, et al. Post-acute sequelae of COVID-19 six to 12 months after infection: population based study. Br Med J. (2022) 379:e071050. 10.1136/bmj-2022-071050</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-071050</ArticleId><ArticleId IdType="pmc">PMC9557001</ArticleId><ArticleId IdType="pubmed">36229057</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Li X, Gu X, Zhang H, Ren L, Guo L, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. (2022) 10(9):863&#x2013;76. 10.1016/S2213-2600(22)00126-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00126-6</ArticleId><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Bek LM, Berentschot JC, Heijenbrok-Kal MH, Huijts S, van Genderen ME, Vlake JH, et al. Symptoms persisting after hospitalisation for COVID-19: 12 months interim results of the CO-FLOW study. ERJ Open Res. (2022) 8(4):355. 10.1183/23120541.00355-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00355-2022</ArticleId><ArticleId IdType="pmc">PMC9421428</ArticleId><ArticleId IdType="pubmed">36284829</ArticleId></ArticleIdList></Reference><Reference><Citation>de Ridder D, Geenen R, Kuijer R, van Middendorp H. Psychological adjustment to chronic disease. Lancet. (2008) 372(9634):246&#x2013;55. 10.1016/S0140-6736(08)61078-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(08)61078-8</ArticleId><ArticleId IdType="pubmed">18640461</ArticleId></ArticleIdList></Reference><Reference><Citation>Szende A, Janssen B, Cabases J. Self-reported population health: An international perspective based on EQ-5D. (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">29787044</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Herck M, Go&#xeb;rtz YMJ, Houben-Wilke S, Machado FVC, Meys R, Delbressine JM, et al. Severe fatigue in long COVID: web-based quantitative follow-up study in members of online long COVID support groups. J Med Internet Res. (2021) 23(9):e30274. 10.2196/30274</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/30274</ArticleId><ArticleId IdType="pmc">PMC8457337</ArticleId><ArticleId IdType="pubmed">34494964</ArticleId></ArticleIdList></Reference><Reference><Citation>Twomey R, DeMars J, Franklin K, Culos-Reed SN, Weatherald J, Wrightson JG. Chronic fatigue and postexertional malaise in people living with long COVID: an observational study. Phys Ther. (2022) 102(4):pzac005. 10.1093/ptj/pzac005</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/pzac005</ArticleId><ArticleId IdType="pmc">PMC9383197</ArticleId><ArticleId IdType="pubmed">35079817</ArticleId></ArticleIdList></Reference><Reference><Citation>Statistics Netherlands (CBS). Risico op angststoornis of depressie onder jongvolwassenen toegenomen (2021). Available at:
https://www.cbs.nl/nl-nl/nieuws/2021/26/risico-op-angststoornis-of-depressie-onder-jongvolwassenen-toegenomen
(Accessed December 14, 2022).</Citation></Reference><Reference><Citation>Schou TM, Joca S, Wegener G, Bay-Richter C. Psychiatric and neuropsychiatric sequelae of COVID-19&#x2014;a systematic review. Brain Behav Immun. (2021) 97:328&#x2013;48. 10.1016/j.bbi.2021.07.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.07.018</ArticleId><ArticleId IdType="pmc">PMC8363196</ArticleId><ArticleId IdType="pubmed">34339806</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanton AL, Revenson TA, Tennen H. Health psychology: psychological adjustment to chronic disease. Annu Rev Psychol. (2007) 58:565&#x2013;92. 10.1146/annurev.psych.58.110405.085615</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.psych.58.110405.085615</ArticleId><ArticleId IdType="pubmed">16930096</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson K, Kristoffersen DT, Dell'Isola A, Kiadaliri A, Turkiewicz A, Runhaar J, et al. Post-COVID medical complaints following infection with SARS-CoV-2 omicron vs Delta variants. Nat Commun. (2022) 13(1):7363. 10.1038/s41467-022-35240-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-35240-2</ArticleId><ArticleId IdType="pmc">PMC9709355</ArticleId><ArticleId IdType="pubmed">36450749</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Notarte KI, Peligro PJ, Velasco JV, Ocampo MJ, Henry BM, et al. Long-COVID symptoms in individuals infected with different SARS-CoV-2 variants of concern: a systematic review of the literature. Viruses. (2022) 14(12):2629. 10.3390/v14122629</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122629</ArticleId><ArticleId IdType="pmc">PMC9785120</ArticleId><ArticleId IdType="pubmed">36560633</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. EClinicalMedicine. (2022) 53:101624. 10.1016/j.eclinm.2022.101624</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Coretti S, Ruggeri M, McNamee P. The minimum clinically important difference for EQ-5D index: a critical review. Expert Rev Pharmacoecon Outcomes Res. (2014) 14(2):221&#x2013;33. 10.1586/14737167.2014.894462</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14737167.2014.894462</ArticleId><ArticleId IdType="pubmed">24625040</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. (2022) 28(8):1706&#x2013;14. 10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallenburg I, Helderman JK, Jeurissen P, Bal R. Unmasking a health care system: the Dutch policy response to the COVID-19 crisis. Health Econ Policy Law. (2022) 17(1):27&#x2013;36. 10.1017/S1744133121000128</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1744133121000128</ArticleId><ArticleId IdType="pmc">PMC8007948</ArticleId><ArticleId IdType="pubmed">33663625</ArticleId></ArticleIdList></Reference><Reference><Citation>Berentschot JC, Heijenbrok-Kal MH, Bek LM, Huijts SM, van Bommel J, van Genderen ME, et al. Physical recovery across care pathways up to 12 months after hospitalization for COVID-19: a multicenter prospective cohort study (CO-FLOW). Lancet Reg Health Eur. (2022) 22:100485. 10.1016/j.lanepe.2022.100485</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100485</ArticleId><ArticleId IdType="pmc">PMC9402257</ArticleId><ArticleId IdType="pubmed">36039177</ArticleId></ArticleIdList></Reference><Reference><Citation>Strom JL, Egede LE. The impact of social support on outcomes in adult patients with type 2 diabetes: a systematic review. Curr Diab Rep. (2012) 12(6):769&#x2013;81. 10.1007/s11892-012-0317-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11892-012-0317-0</ArticleId><ArticleId IdType="pmc">PMC3490012</ArticleId><ArticleId IdType="pubmed">22949135</ArticleId></ArticleIdList></Reference><Reference><Citation>Fincham JE. Response rates and responsiveness for surveys, standards, and the journal. Am J Pharm Educ. (2008) 72(2):43. 10.5688/aj720243</Citation><ArticleIdList><ArticleId IdType="doi">10.5688/aj720243</ArticleId><ArticleId IdType="pmc">PMC2384218</ArticleId><ArticleId IdType="pubmed">18483608</ArticleId></ArticleIdList></Reference><Reference><Citation>Ormiston CK, &#x15a;wi&#x105;tkiewicz I, Taub PR. Postural orthostatic tachycardia syndrome as a sequela of COVID-19. Heart Rhythm. (2022) 19(11):1880&#x2013;9. 10.1016/j.hrthm.2022.07.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2022.07.014</ArticleId><ArticleId IdType="pmc">PMC9287587</ArticleId><ArticleId IdType="pubmed">35853576</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>